Trial with laquinimod in primary progressive MS fails...
Posted: Mon Dec 04, 2017 6:48 am
Phase II trial with laquinimod in primary progressive MS fails to deliver
Active Biotech drug, laquinimod has failed a phase II trial in primary progressive MS.
Laquinimod a once-daily oral drug targets neurodegeneration and inflammation with a novel mechanism of action being developed for the treatment of relapsing remitting MS (RRMS), primary-progressive MS (PPMS) and Huntington disease...Read more - http://www.ms-uk.org/phase-ii-trial-laq ... ls-deliver
Active Biotech drug, laquinimod has failed a phase II trial in primary progressive MS.
Laquinimod a once-daily oral drug targets neurodegeneration and inflammation with a novel mechanism of action being developed for the treatment of relapsing remitting MS (RRMS), primary-progressive MS (PPMS) and Huntington disease...Read more - http://www.ms-uk.org/phase-ii-trial-laq ... ls-deliver